Drug fusions and conjugates

Details for Australian Patent Application No. 2009231439 (hide)

Owner Glaxo Group Limited

Inventors Holt, Lucy J.; Herring, Christopher; Jespers, Laurent

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009231439

PCT Pub. Number WO2009/121804

Priority 61/086,891 07.08.08 US; 61/040,796 31.03.08 US

Filing date 27 March 2009

Wipo publication date 8 October 2009

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/121804 Priority application(s): WO2009/121804

28 April 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Holt, Lucy J.; Herring, Christopher; Jespers, Laurent and Hamilton, Bruce

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009231448-Stationary household appliance, in particular a dishwasher

2009231433-System for transmitting amplified audio signals to a user